Insider · CIK 0001436880
David H Li
Files at HXL (HEXCEL CORP /DE/), NGVT (Ingevity Corp). First filing -, latest -.
David H Li files SEC Form 4 as director, CEO and president at HXL (HEXCEL CORP /DE/), and also at NGVT (Ingevity Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David H Li has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 27 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 3, 2026 | HXL HEXCEL CORP /DE/ | MOption exercise Common Stock | +340 | $0.00 | $0 | 4,952 | 8 d ago |
| Oct 2, 2026 | HXL HEXCEL CORP /DE/ | AGrant or award Restricted Stock Unitsderivative | +287 | $0.00 | $0 | 287 | 8 d ago |
| Oct 3, 2026 | HXL HEXCEL CORP /DE/ | MOption exercise Restricted Stock Unitsderivative | -340 | $0.00 | $0 | 0 | 8 d ago |
| May 18, 2026 | HXL HEXCEL CORP /DE/ | AGrant or award Restricted Stock Unitsderivative | +1,792 | $0.00 | $0 | 1,792 | May 19, 2026 |
| May 8, 2026 | HXL HEXCEL CORP /DE/ | MOption exercise Common Stock | +2,697 | $0.00 | $0 | 4,239 | May 8, 2026 |
| May 8, 2026 | HXL HEXCEL CORP /DE/ | MOption exercise Restricted Stock Unitsderivative | -2,697 | $0.00 | $0 | 0 | May 8, 2026 |
| Apr 7, 2026 | NGVT Ingevity Corp | FTax withholding Common Stock | -13,102 | $70.57 | $925k | 144,210 | Apr 9, 2026 |
| Apr 7, 2026 | NGVT Ingevity Corp | FTax withholding Common Stock | -3,574 | $70.57 | $252k | 140,636 | Apr 9, 2026 |
| Apr 4, 2026 | HXL HEXCEL CORP /DE/ | MOption exercise Common Stock | +457 | $0.00 | $0 | 1,542 | Apr 6, 2026 |
| Apr 3, 2026 | HXL HEXCEL CORP /DE/ | AGrant or award Restricted Stock Unitsderivative | +277 | $0.00 | $0 | 277 | Apr 6, 2026 |
| Apr 4, 2026 | HXL HEXCEL CORP /DE/ | MOption exercise Restricted Stock Unitsderivative | -457 | $0.00 | $0 | 0 | Apr 6, 2026 |
| Feb 27, 2026 | NGVT Ingevity Corp | AGrant or award Common Stock | +38,179 | $0.00 | $0 | 156,890 | Mar 3, 2026 |
| Jan 10, 2026 | HXL HEXCEL CORP /DE/ | MOption exercise Common Stock | +341 | $0.00 | $0 | 1,085 | Jan 13, 2026 |
| Jan 9, 2026 | HXL HEXCEL CORP /DE/ | AGrant or award Restricted Stock Unitsderivative | +272 | $0.00 | $0 | 272 | Jan 13, 2026 |
| Jan 10, 2026 | HXL HEXCEL CORP /DE/ | MOption exercise Restricted Stock Unitsderivative | -341 | $0.00 | $0 | 0 | Jan 13, 2026 |
| Oct 3, 2025 | HXL HEXCEL CORP /DE/ | AGrant or award Restricted Stock Unitsderivative | +340 | $0.00 | $0 | 340 | Oct 7, 2025 |
| Jul 11, 2025 | HXL HEXCEL CORP /DE/ | AGrant or award Restricted Stock Unitsderivative | +373 | $0.00 | $0 | 373 | Jul 15, 2025 |
| May 8, 2025 | HXL HEXCEL CORP /DE/ | AGrant or award Restricted Stock Unitsderivative | +2,697 | $0.00 | $0 | 2,697 | May 12, 2025 |
| May 7, 2025 | HXL HEXCEL CORP /DE/ | MOption exercise Common Stock | +744 | $0.00 | $0 | 744 | May 8, 2025 |
| May 7, 2025 | HXL HEXCEL CORP /DE/ | MOption exercise Restricted Stock Unitsderivative | -744 | $0.00 | $0 | 0 | May 8, 2025 |
| Apr 7, 2025 | NGVT Ingevity Corp | AGrant or award Employee Stock Option (right-to-buy)derivative | +123,229 | $0.00 | $0 | 123,229 | Apr 17, 2025 |
| Apr 7, 2025 | NGVT Ingevity Corp | AGrant or award Common Stock | +86,669 | $0.00 | $0 | 86,669 | Apr 9, 2025 |
| Apr 7, 2025 | NGVT Ingevity Corp | AGrant or award Common Stock | +31,516 | $0.00 | $0 | 118,185 | Apr 9, 2025 |
| Apr 7, 2025 | NGVT Ingevity Corp | AGrant or award Employee Stock Option (right-to-buy)derivative | +177,305 | $0.00 | $0 | 177,305 | Apr 9, 2025 |
| Apr 4, 2025 | HXL HEXCEL CORP /DE/ | AGrant or award Restricted Stock Unitsderivative | +457 | $0.00 | $0 | 457 | Apr 8, 2025 |
| Jan 10, 2025 | HXL HEXCEL CORP /DE/ | AGrant or award Restricted Stock Unitsderivative | +341 | $0.00 | $0 | 341 | Jan 13, 2025 |
| Jan 1, 2025 | HXL HEXCEL CORP /DE/ | AGrant or award Restricted Stock Unitsderivative | +744 | $0.00 | $0 | 744 | Jan 3, 2025 |
Questions about David H Li
Answered from the filings on this page, as of the latest one.
Is David H Li buying or selling?
David H Li has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David H Li's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David H Li has 0.
Where does David H Li file Form 4?
David H Li has filed Form 4 at HXL (HEXCEL CORP /DE/); NGVT (Ingevity Corp) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.